Karin Bornfeldt received her PhD from Linköping University in Sweden in 1991. Later that year, she came to the University of Washington (UW) to do a postdoctoral fellowship in the laboratory of Dr. Russell Ross, a leader in the field of cardiovascular medicine. She also worked closely with Dr. Edwin Krebs on signal transduction in vascular cells. She was appointed to the faculty of the UW in 1995, and is now Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition, and Professor of Pathology. She serves as Associate Director of the Diabetes and Obesity Center of Excellence and Deputy Director of the UW’s Diabetes Research Center (DRC). She also directs the DRC Viral Vector and Transgenic Mouse Core.
Dr. Bornfeldt is actively involved in graduate student teaching and has served on more than 20 Doctoral Supervisory Committees in Pathology, Molecular and Cellular Biology, Pharmacology, and Nutritional Sciences. She is a current or past member of the editorial boards of the Journal of Clinical Investigation, Circulation Research, Diabetes, and the Journal of Biological Chemistry.
Research in the Bornfeldt lab focuses on the cellular and molecular mechanisms of vascular complications of diabetes. Currently, the roles of acyl-CoA synthetases, glucose, and S100A9 in vascular complications of diabetes are topics of great interest in the lab.